Lupin has received the Food and Drug Administration's OK for generic Onfi, and tentative nod for generic Adcirca, with a value of $601.2 million and $503.8 million, respectively.
Pleased that the Farm Bill includes the Hemp Farming Act, the Council for Responsible Nutrition noted its disappointment that it omits the SNAP Vitamin and Supplements Improvement Act.